As a reminder, BCBSRI will implement the final of its three pricing adjustments to its professional drug reimbursement for commercial products effective 1 de abril de 2019. For dates of service on or after 1 de abril de 2019, BCBSRI will reimburse 106% of ASP for its commercial products. (Please note that reimbursement for Medicare Advantage products is already set at 106% of ASP.) BCBSRI will continue its policy of updating pricing with the most current ASP values available on a quarterly basis. The updated fee schedule for 1 de abril de 2019 (second quarter of 2019) will be posted on bcbsri.com prior to 1 de abril de 2019.